Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV‐infected patients in Cambodia
- 19 November 2010
- journal article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 16 (2) , 205-213
Abstract
Objectives To report immunovirological outcomes and resistance patterns in adults treated with triple combination antiretroviral therapy (cART) for 4 years in an HIV programme of Phnom Penh, Cambodia. Methods It is a longitudinal study and cross-sectional evaluation of adults receiving cART for 4 years. CD4 cell counts and HIV-1 RNA were quantified, and resistance patterns were determined. Drug-related toxicity was assessed by clinicians and through laboratory testing. Results After 4 years of cART start, the cumulative probability of retention in care was 0.80 and survival among patients not lost to follow-up was 0.85. A total of 349 patients (98% of eligible) participated in the cross-sectional evaluation. Ninety per cent were receiving first-line therapy, 29% stavudine- and 58% zidovudine-containing regimens (compared with 94% and 3% at cART initiation). Ninety-three per cent of patients were clinically asymptomatic, and severe lipodystrophy and dyslipidemia were diagnosed in 7.2% and 4.0%, respectively. Good treatment adherence was reported by 83% of patients. Median CD4 T-cell count was 410 cells/μl [IQR 290-511], and 90% of patients had >200 cells/μl. Only 15 (4%) patients had detectable HIV viral load (eight had <200 CD4 cells/μl), five had thymidine analogue mutations, and nine were resistant to two drug classes. In an intention-to-treat analysis, 26.1% (95% CI 22.0-30.5) of patients had failed first-line therapy. Conclusions In this Cambodian cohort of adults who started cART at an advanced stage of HIV disease, we observed good clinical and immunovirological outcomes and self-reported treatment adherence at 4 years of therapyKeywords
This publication has 30 references indexed in Scilit:
- Incomplete Peripheral CD4+Cell Count Restoration in HIV‐Infected Patients Receiving Long‐Term Antiretroviral TreatmentClinical Infectious Diseases, 2009
- Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment ProgramAIDS, 2008
- Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studiesAIDS, 2008
- The Relationship Between Resistance and Adherence in Drug-Naive Individuals Initiating HAART Is Specific to Individual Drug ClassesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Body Shape and Metabolic Abnormalities in Thai HIV-Infected PatientsAIDS Research and Human Retroviruses, 2007
- Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort studyThe Lancet, 2007
- Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatmentHIV Medicine, 2007
- Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and FacilitatorsPLOS Medicine, 2006
- Risk factors for the HIV‐associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatmentHIV Medicine, 2002
- StavudineDrugs, 1999